Wasman Jane Insider Trades

Insider Trading History

Track insider trading activity for Wasman Jane. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $751k 18,250 shares
Last Trade
May 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 5,750 shares
$29.01
$41.17
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
Director
Holding Value $1.24M 92,900 shares
Last Trade
Jan 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$202k 50,000 shares
$4.04
$13.39
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
Director
Holding Value $407k 30,400 shares
Last Trade
May 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.8k 20,000 shares
$1.69
$13.39
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $515k 12,500 shares
Last Trade
May 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.9k 3,000 shares
$18.95
$41.17
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
Director
Holding Value $307k 22,900 shares
Last Trade
Jan 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.6k 18,500 shares
$0.95
$13.39
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $4.12M 100,000 shares
Last Trade
May 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 30,000 shares
$9.07
$41.17
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
Director
Holding Value $139k 10,400 shares
Last Trade
Jan 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.2k 10,000 shares
$0.52
$13.39
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $3.09M 75,000 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$396k 30,000 shares
$13.20
$41.17
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
Director
Holding Value $127k 9,500 shares
Last Trade
Feb 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.7k 9,500 shares
$3.34
$13.39
Athersys
Athersys ATHX
Director
Holding Value $474 35,141 shares
Last Trade
Jan 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.3k 22,321 shares
$1.09
$0.01
Athersys
Athersys ATHX
Director
Holding Value $865 64,084 shares
Last Trade
Sep 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.5k 32,042 shares
$1.95
$0.01
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $1.24M 30,000 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$603k 30,000 shares
$20.10
$41.17
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
Director
Holding Value $95.4k 7,125 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38k 7,125 shares
$5.34
$13.39
Athersys
Athersys ATHX
Director
Holding Value $675 50,000 shares
Last Trade
Jun 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77k 50,000 shares
$1.54
$0.01
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $1.24M 30,000 shares
Last Trade
May 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.09M 30,000 shares
$36.40
$41.17
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
Director
Holding Value $100k 7,500 shares
Last Trade
Mar 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60k 7,500 shares
$8.00
$13.39
Athersys
Athersys ATHX
Director
Holding Value $1.35k 100,000 shares
Last Trade
Nov 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$188k 100,000 shares
$1.88
$0.01
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $2.26M 55,000 shares
Last Trade
May 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$971k 55,000 shares
$17.65
$41.17
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
Director
Holding Value $87k 6,500 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.3k 6,500 shares
$1.89
$13.39
Acorda Therapeutics
Acorda Therapeutics ACOR
President, Intl And GC
Holding Value $77.6k 117,420 shares
Last Trade
Dec 02, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$21.5k 2,227 shares
$9.66
$0.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up